Clearmind Medicine Inc. Stock Canadian Securities Exchange
Equities
CYN
CA1850534027
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -13.51% | -58.01% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 2.45M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.36M | Net income 2023 | -8M -10.99M | EV / Sales 2022 | - |
Net cash position 2022 | 388K 533K | Net cash position 2023 | 5.51M 7.57M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.12% | 30.74B | |
-8.64% | 26.03B | |
+11.81% | 25.92B | |
+45.08% | 14.13B | |
+32.85% | 12.73B | |
-7.19% | 11.29B |
- Stock Market
- Equities
- CMND Stock
- CYN Stock